XML 72 R51.htm IDEA: XBRL DOCUMENT v3.23.1
Restatement of Previously Issued Consolidated Financial Statements - Consolidated Statements of Operations and Comprehensive Loss (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Error Corrections and Prior Period Adjustments Restatement [Line Items]                            
Revenue $ 59,216 $ 71,757 $ 91,864 $ 108,200 $ 100,524 $ 88,562 $ 82,868 $ 67,377 $ 59,684 $ 58,614 $ 43,372 $ 269,709 $ 380,154 $ 229,047
Cost of revenue 7,599 9,003 9,200 8,422 8,179 4,386 4,256 3,475 3,102 2,937 2,767 30,718 25,243 12,281
Research and development 7,937 18,253 18,650 15,744 13,066 10,140 7,282 9,972 4,369 4,518 4,366 52,265 46,232 23,225
Sales and marketing 51,480 73,731 117,345 155,404 114,828 99,998 96,461 80,739 73,577 52,785 47,168 277,014 466,691 254,269
General and administrative 20,936 26,881 92,723 34,248 48,514 25,601 27,439 18,006 7,905 11,686 4,865 163,018 135,802 42,462
Total costs and expenses 139,182 127,868 237,918 213,818 184,587 140,125 135,438 112,192 88,953 71,926 59,166 691,066 673,968 332,237
Loss from operations (79,966) (56,111) (146,054) (105,618) (84,063) (51,563) (52,570) (44,815) (29,269) (13,312) (15,794) (421,357) (293,814) (103,190)
Loss before income taxes (83,345) (62,766) (149,777) (100,739) 29,429 (81,103) (54,652) (68,543) (43,509) (20,853) (16,059) (439,220) (207,065) (148,964)
Benefit for income taxes 120 155 213 (314) (18,933) 65 42 15 47 28 25 (345) (19,140) 115
Net loss $ (83,225) $ (62,611) $ (149,564) $ (100,425) $ 48,362 $ (81,168) $ (54,694) $ (68,558) $ (43,556) $ (20,881) $ (16,084) $ (438,875) $ (187,925) $ (149,079)
Net income (loss) loss per share attributable to common stockholders:                            
Basic (in dollars per share) $ (0.20) $ (0.16) $ (0.37) $ (0.25) $ 0.12 $ (0.21) $ (0.15) $ (0.23) $ (0.15) $ (0.07) $ (0.06) $ (1.07) $ (0.49) $ (0.51)
Diluted (in dollars per share) $ (0.20) $ (0.16) $ (0.37) $ (0.25) $ (0.16) $ (0.21) $ (0.16) $ (0.23) $ (0.15) $ (0.07) $ (0.06) $ (1.07) $ (0.71) $ (0.51)
Total comprehensive loss $ (83,086) $ (63,188) $ (151,610) $ (100,673) $ 48,362 $ (81,168) $ (54,694) $ (68,558) $ (43,556) $ (20,881) $ (16,084) $ (440,190) $ (188,173) $ (149,079)
As Reported                            
Error Corrections and Prior Period Adjustments Restatement [Line Items]                            
Revenue 60,255 73,335 93,438 108,849 102,072 89,491 83,677 67,723 59,955 58,878 43,559   384,089 230,115
Cost of revenue 7,555 9,020 9,265 8,422 7,647 4,386 4,256 3,475 3,102 2,937 2,767   24,711 12,281
Research and development 8,354 18,529 18,653 15,433 13,162 10,140 7,282 9,972 4,369 4,518 4,366   46,017 23,225
Sales and marketing 51,773 73,185 117,332 155,080 114,531 99,523 96,323 79,560 73,187 52,369 46,825   465,457 251,941
General and administrative 20,280 26,712 92,792 33,934 48,376 25,432 27,284 17,953 7,861 11,642 4,833   135,026 42,289
Total costs and expenses 135,543 127,446 238,042 212,869 183,716 139,481 135,145 110,960 88,519 71,466 58,791   671,211 329,736
Loss from operations (75,288) (54,111) (144,604) (104,020) (81,644) (49,990) (51,468) (43,237) (28,564) (12,588) (15,232)   (287,122) (99,621)
Loss before income taxes (78,667) (60,766) (148,326) (99,141) 31,848 (79,530) (53,550) (66,965) (42,804) (20,129) (15,497)   (200,373) (145,395)
Benefit for income taxes 120 155 213 (170) (18,933) 65 42 15 47 28 25   (18,996)  
Net loss $ (78,547) $ (60,611) $ (148,113) $ (98,971) $ 50,781 $ (79,595) $ (53,592) $ (66,980) $ (42,851) $ (20,157) $ (15,522)   $ (181,377) $ (145,510)
Net income (loss) loss per share attributable to common stockholders:                            
Basic (in dollars per share) $ (0.19) $ (0.15) $ (0.37) $ (0.25) $ 0.13 $ (0.21) $ (0.15) $ (0.22) $ (0.14) $ (0.07) $ (0.06)   $ (0.47) $ (0.49)
Diluted (in dollars per share) $ (0.19) $ (0.15) $ (0.37) $ (0.25) $ (0.16) $ (0.21) $ (0.16) $ (0.22) $ (0.14) $ (0.07) $ (0.06)   $ (0.69) $ (0.49)
Total comprehensive loss $ (78,408) $ (61,188) $ (150,159) $ (99,219) $ 50,781 $ (79,595) $ (53,592) $ (66,980) $ (42,851) $ (20,157) $ (15,522)   $ (181,625) $ (145,510)
Revision of Prior Period, Adjustment | End-User Liability                            
Error Corrections and Prior Period Adjustments Restatement [Line Items]                            
Revenue (71) (83) (52) (41) (34) (38) (25) (25) (19) (24) (17)   (138) (87)
Cost of revenue 0 0 0 0 0 0 0 0 0 0 0   0 0
Research and development 0 0 0 0 0 0 0 0 0 0 0   0 0
Sales and marketing (84) 1,053 630 531 636 475 138 1,179 390 416 343   1,780 2,328
General and administrative 0 0 0 0 0 0 0 0 0 0 0   0 0
Total costs and expenses (84) 1,053 630 531 636 475 138 1,179 390 416 343   1,780 2,328
Loss from operations 13 (1,136) (682) (572) (670) (513) (163) (1,204) (409) (440) (360)   (1,918) (2,415)
Loss before income taxes 13 (1,136) (682) (572) (670) (513) (163) (1,204) (409) (440) (360)   (1,918) (2,415)
Benefit for income taxes 0 0 0 0 0 0 0 0 0 0 0   0  
Net loss $ 13 $ (1,136) $ (682) $ (572) $ (670) $ (513) $ (163) $ (1,204) $ (409) $ (440) $ (360)   $ (1,918) $ (2,415)
Net income (loss) loss per share attributable to common stockholders:                            
Basic (in dollars per share) $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0   $ 0 $ (0.01)
Diluted (in dollars per share) $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0   $ 0 $ (0.01)
Total comprehensive loss $ 13 $ (1,136) $ (682) $ (572) $ (670) $ (513) $ (163) $ (1,204) $ (409) $ (440) $ (360)   $ (1,918) $ (2,415)
Revision of Prior Period, Adjustment | Indirect Taxes                            
Error Corrections and Prior Period Adjustments Restatement [Line Items]                            
Revenue (856) (1,470) (1,435) (1,114) (1,008) (891) (784) (321) (252) (240) (170)   (3,797) (981)
Cost of revenue 0 0 0 0 0 0 0 0 0 0 0   0 0
Research and development 0 0 0 0 0 0 0 0 0 0 0   0 0
Sales and marketing 0 0 0 0 0 0 0 0 0 0 0   0 0
General and administrative 152 184 (76) 192 176 169 155 53 44 44 32   691 173
Total costs and expenses 152 184 (76) 192 176 169 155 53 44 44 32   691 173
Loss from operations (1,008) (1,654) (1,359) (1,306) (1,184) (1,060) (939) (374) (296) (284) (202)   (4,488) (1,154)
Loss before income taxes (1,008) (1,654) (1,359) (1,306) (1,184) (1,060) (939) (374) (296) (284) (202)   (4,488) (1,154)
Benefit for income taxes 0 0 0 0 0 0 0 0 0 0 0   0  
Net loss $ (1,008) $ (1,654) $ (1,359) $ (1,306) $ (1,184) $ (1,060) $ (939) $ (374) $ (296) $ (284) $ (202)   $ (4,488) $ (1,154)
Net income (loss) loss per share attributable to common stockholders:                            
Basic (in dollars per share) $ 0 $ 0 $ 0 $ 0 $ (0.01) $ 0 $ 0 $ 0 $ 0 $ 0 $ 0   $ (0.01) $ 0
Diluted (in dollars per share) $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0   $ (0.01) $ 0
Total comprehensive loss $ (1,008) $ (1,654) $ (1,359) $ (1,306) $ (1,184) $ (1,060) $ (939) $ (374) $ (296) $ (284) $ (202)   $ (4,488) $ (1,154)
Revision of Prior Period, Adjustment | Other Adjustments                            
Error Corrections and Prior Period Adjustments Restatement [Line Items]                            
Revenue (112) (25) (87) 506 (506) 0 0 0 0 0 0   0 0
Cost of revenue 289 (17) (65) 0 532 0 0 0 0 0 0   532 0
Research and development (417) (276) (3) 311 (96) 0 0 0 0 0 0   215 0
Sales and marketing (207) (507) (617) (207) (339) 0 0 0 0 0 0   (546) 0
General and administrative 525 (15) 7 122 (38) 0 0 0 0 0 0   85 0
Total costs and expenses 190 (815) (678) 226 59 0 0 0 0 0 0   286 0
Loss from operations (302) 790 591 280 (565) 0 0 0 0 0 0   (286) 0
Loss before income taxes (302) 790 590 280 (565) 0 0 0 0 0 0   (286) 0
Benefit for income taxes 0 0 0 (144) 0 0 0 0 0 0 0   (144)  
Net loss $ (302) $ 790 $ 590 $ 424 $ (565) $ 0 $ 0 $ 0 $ 0 $ 0 $ 0   $ (142) $ 0
Net income (loss) loss per share attributable to common stockholders:                            
Basic (in dollars per share) $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0   $ 0 $ 0
Diluted (in dollars per share) $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0   $ 0 $ 0
Total comprehensive loss $ (302) $ 790 $ 590 $ 424 $ (565) $ 0 $ 0 $ 0 $ 0 $ 0 $ 0   $ (142) $ 0
Revision of Prior Period, Adjustment | Other Adjustments, Excluding Immaterial Adjustments                            
Error Corrections and Prior Period Adjustments Restatement [Line Items]                            
Cost of revenue                         500  
Research and development                         200  
Sales and marketing                         200  
General and administrative                         $ 100